Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.350
+0.055 (4.25%)
At close: Nov 6, 2026, 4:00 PM EST
1.330
-0.020 (-1.48%)
After-hours: Nov 6, 2026, 7:30 PM EST

Akso Health Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,1571,953425170839
Market Cap Growth
23.27%359.39%150.55%1990.59%-78.99%28.42%
Enterprise Value
1,1591,944341171835
Last Close Price
1.352.281.181.160.351.69

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-5.085.085.085.085.08
PS Ratio
83.61141.2228.7770.290.626.44
PB Ratio
6.3910.802.131.230.923.15
P/TBV Ratio
6.3910.802.361.230.933.15
P/FCF Ratio
--415.76125.59--
P/OCF Ratio
--361.20125.59--
PEG Ratio
-0.510.510.510.510.51

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
83.77140.5623.0570.650.595.86
EV/FCF Ratio
--333.10126.24--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.010.010.010.011.103.03
Debt / FCF Ratio
--2.041.48--
Net Debt / Equity Ratio
0.010.01-0.87-0.600.201.53
Net Debt / EBITDA Ratio
-1.35-1.3598.21--0.12-7.70
Net Debt / FCF Ratio
-0.17-0.17-170.28-61.55-0.54-2.17
Asset Turnover
0.070.070.080.030.320.13
Inventory Turnover
70.9270.9278.962.442.51-
Quick Ratio
0.170.1712.8323.701.340.37
Current Ratio
21.7721.7714.2039.521.761.24
Return on Equity (ROE)
-9.85%-9.85%-80.26%-12.38%-123.87%-27.75%
Return on Assets (ROA)
-1.24%-1.24%-1.37%-6.64%-21.42%-3.25%
Return on Invested Capital (ROIC)
-2.18%-3.84%-9.78%-26.24%-68.50%-10.64%
Return on Capital Employed (ROCE)
-2.20%-2.20%-2.00%-6.20%-161.40%-20.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-2.22%-0.96%-31.75%-5.57%-16.75%-43.61%
FCF Yield
-1.11%-0.66%0.24%0.80%-40.08%-22.33%
Buyback Yield / Dilution
-153.50%-153.50%-504.37%-106.30%-15.07%-22.06%
Total Shareholder Return
-153.50%-153.50%-504.37%-106.30%-15.07%-22.06%
SEC Filings: 10-K · 10-Q